Skip to content

Clinical observation of parotid injection guided by B-ultrasound in the treatment of salivation in Parkinson's disease

Clinical observation of parotid injection guided by B-ultrasound in the treatment of salivation in Parkinson's disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052061
Enrollment
Unknown
Registered
2021-10-16
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Treatment group:Drug injection and conventional treatment
Control group:Conventional treatment

Sponsors

The First Affiliated Hospital of Anhui University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet PD diagnostic criteria; 2. With salivation; 3. No patients with lung infection (the diagnostic criteria for pulmonary infection are based on the relevant diagnostic criteria in the Diagnostic Criteria for Nosocomial Infection: the clinical manifestations are mainly cough, difficult expectoration of sputum, shortness of breath, respiratory failure, etc.; the pathogen was positive); 4. Patients cooperated with treatment and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Type A botulinum toxin is contraindicated, such as muscle weakness or botulinum toxin allergy; 2. There are serious primary diseases of other systems.

Design outcomes

Primary

MeasureTime frame
Salivation severity and frequency scale score;Salivation scale score for Parkinson's disease;

Secondary

MeasureTime frame
HAMD(Hamilton Depression Scale);HAMA(Hamilton Anxiety Scale);PDQ-39(Quality of Life Questionnaire for Parkinson's Disease);PDSS-2;Rosenberg self esteem scale;

Countries

China

Contacts

Public ContactLi Jun

The First Affiliated Hospital of Anhui University of Chinese Medicine

18788899199@qq.com+86 18788899199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026